USFDA inspections to be less disruptive for Indian pharma sector: Report
Indian pharma companies have increasingly de-risked their operations by slowly and steadily increasing sales to non-US markets, says India Ratings and Research.
drugs pharma industry
January 2023
December 2022
September 2022
April 2022
November 2021
April 2020
July 2019
April 2019
Lupin launches asthma drug DIFIZMA; stock gains
The pharma major has launched a novel fixed-dose triple drug combination ‘DIFIZMA’ to treat inadequately controlled asthma.
Sun Pharma gets U.S. FDA warning for Halol facility; share falls 2%
The pharma company received a warning letter from the U.S. FDA for violations of manufacturing standards at the Halol facility in Gujarat.
Lupin shares rise 4% on nod for Mirabegron tablets
Lupin has received U.S. FDA approval for Mirabegron Extended-Release Tablets used for the treatment of overactive bladder.
Customs seize 5.85 kg cocaine in biggest-ever haul at Delhi airport
The seizure is the biggest haul at any airport in India.
Traders’ body presses charges of 'drug peddling' against Amazon
CAIT demands action against senior management of the ecommerce giant after marijuana found in a fulfillment centre.
India can reprioritise its global commitments
In a post-coronavirus world, India can become a major provider of global public-goods and services like healthcare.
Dr Google, second opinions, and the informed patient
The impact of today’s information-centric culture on healthcare is far-reaching.
OTC drugs: Can pharma move fast-enough?
With a strong distribution network, FMCG companies are shifting gears and preparing to cater to the needs of a more health conscious rural population with OTC medical products.
